MovDisordV3, PascalFrancis, Curation, bibRecord, 000911

Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease

Identifieur interne : 000911 ( PascalFrancis/Curation ); précédent : 000910; suivant : 000912

Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease

Auteurs : Masataka Nishimura [Japon] ; Sadako Kuno [Japon] ; Ikuko Mizuta [Japon] ; Mitsuhiro Ohta [Japon] ; Hirofumi Maruyama [Japon] ; Ryuji Kaji [Japon] ; Hideshi Kawakami [Japon]

Source :

Movement disorders [ 0885-3185 ] ; 2003.

RBID : Pascal:04-0010854

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Sporadique, Polymorphisme, Génotype, Allèle, Protéine MCP1, Récepteur chimiokine CCR2, Gène, Facteur risque, Déterminisme génétique, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Allele, CCR2 chemokine receptor, Gene, Genetic determinism, Genotype, Human, Monocyte chemoattractant protein 1, Parkinson disease, Polymorphism, Risk factor, Sporadic.

Abstract

We studied polymorphisms in the genes for monocyte chemoattractant protein 1 (MCP-1) and CC chemokine receptor (CCR)-2 in 171 Parkinson's disease (PD) patients and 340 controls. Although no associations were found in alleles or genotypes, MCP-1 -2518A/G genotype affected the age-at-onset of PD patients. This effect was also detected in a second PD group, suggesting a possible involvement of MCP-1 in PD.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 18`
A06				`@2 8`
A08	`01`	`1`	`ENG`	`@1 Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease`
A11	`01`	`1`		`@1 NISHIMURA (Masataka)`
A11	`02`	`1`		`@1 KUNO (Sadako)`
A11	`03`	`1`		`@1 MIZUTA (Ikuko)`
A11	`04`	`1`		`@1 OHTA (Mitsuhiro)`
A11	`05`	`1`		`@1 MARUYAMA (Hirofumi)`
A11	`06`	`1`		`@1 KAJI (Ryuji)`
A11	`07`	`1`		`@1 KAWAKAMI (Hideshi)`
A14	`01`			`@1 Department of Clinical Neuroscience, Tokushima University Hospital @2 Tokushima @3 JPN @Z 1 aut. @Z 6 aut.`
A14	`02`			`@1 Clinical Research Center, Utano National Hospital @2 Kyoto @3 JPN @Z 2 aut. @Z 3 aut.`
A14	`03`			`@1 Department of Clinical Chemistry, Kobe Pharmaceutical University @2 Kobe @3 JPN @Z 4 aut.`
A14	`04`			`@1 Third Department of Internal Medicine, Hiroshima University School of Medicine @2 Hiroshima @3 JPN @Z 5 aut. @Z 7 aut.`
A20				`@1 953-955`
A21				`@1 2003`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000112695530170`
A44				`@0 0000 @1 © 2004 INIST-CNRS. All rights reserved.`
A45				`@0 11 ref.`
A47	`01`	`1`		`@0 04-0010854`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	`@0 We studied polymorphisms in the genes for monocyte chemoattractant protein 1 (MCP-1) and CC chemokine receptor (CCR)-2 in 171 Parkinson's disease (PD) patients and 340 controls. Although no associations were found in alleles or genotypes, MCP-1 -2518A/G genotype affected the age-at-onset of PD patients. This effect was also detected in a second PD group, suggesting a possible involvement of MCP-1 in PD.`
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Parkinson maladie @5 01`
C03	`01`	`X`	`ENG`	`@0 Parkinson disease @5 01`
C03	`01`	`X`	`SPA`	`@0 Parkinson enfermedad @5 01`
C03	`02`	`X`	`FRE`	`@0 Sporadique @5 02`
C03	`02`	`X`	`ENG`	`@0 Sporadic @5 02`
C03	`02`	`X`	`SPA`	`@0 Esporádico @5 02`
C03	`03`	`X`	`FRE`	`@0 Polymorphisme @5 04`
C03	`03`	`X`	`ENG`	`@0 Polymorphism @5 04`
C03	`03`	`X`	`SPA`	`@0 Polimorfismo @5 04`
C03	`04`	`X`	`FRE`	`@0 Génotype @5 05`
C03	`04`	`X`	`ENG`	`@0 Genotype @5 05`
C03	`04`	`X`	`SPA`	`@0 Genotipo @5 05`
C03	`05`	`X`	`FRE`	`@0 Allèle @5 06`
C03	`05`	`X`	`ENG`	`@0 Allele @5 06`
C03	`05`	`X`	`SPA`	`@0 Alelo @5 06`
C03	`06`	`X`	`FRE`	`@0 Protéine MCP1 @5 07`
C03	`06`	`X`	`ENG`	`@0 Monocyte chemoattractant protein 1 @5 07`
C03	`06`	`X`	`SPA`	`@0 Proteina quimiocaptante monocitos 1 @5 07`
C03	`07`	`X`	`FRE`	`@0 Récepteur chimiokine CCR2 @5 08`
C03	`07`	`X`	`ENG`	`@0 CCR2 chemokine receptor @5 08`
C03	`07`	`X`	`SPA`	`@0 Receptor quimioquina CCR2 @5 08`
C03	`08`	`X`	`FRE`	`@0 Gène @5 09`
C03	`08`	`X`	`ENG`	`@0 Gene @5 09`
C03	`08`	`X`	`SPA`	`@0 Gen @5 09`
C03	`09`	`X`	`FRE`	`@0 Facteur risque @5 17`
C03	`09`	`X`	`ENG`	`@0 Risk factor @5 17`
C03	`09`	`X`	`SPA`	`@0 Factor riesgo @5 17`
C03	`10`	`X`	`FRE`	`@0 Déterminisme génétique @5 18`
C03	`10`	`X`	`ENG`	`@0 Genetic determinism @5 18`
C03	`10`	`X`	`SPA`	`@0 Determinismo genético @5 18`
C03	`11`	`X`	`FRE`	`@0 Homme @5 20`
C03	`11`	`X`	`ENG`	`@0 Human @5 20`
C03	`11`	`X`	`SPA`	`@0 Hombre @5 20`
C07	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 37`
C07	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 38`
C07	`02`	`X`	`ENG`	`@0 Central nervous system disease @5 38`
C07	`02`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 38`
C07	`03`	`X`	`FRE`	`@0 Encéphale pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Cerebral disorder @5 39`
C07	`03`	`X`	`SPA`	`@0 Encéfalo patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 40`
C07	`04`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 40`
C07	`05`	`X`	`FRE`	`@0 Maladie dégénérative @5 41`
C07	`05`	`X`	`ENG`	`@0 Degenerative disease @5 41`
C07	`05`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 41`
N21				`@1 006`
N82				`@1 PSI`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002410

Links to Exploration step

Pascal:04-0010854

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease</title>
<author><name sortKey="Nishimura, Masataka" sort="Nishimura, Masataka" uniqKey="Nishimura M" first="Masataka" last="Nishimura">Masataka Nishimura</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Clinical Neuroscience, Tokushima University Hospital</s1>
<s2>Tokushima</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Kuno, Sadako" sort="Kuno, Sadako" uniqKey="Kuno S" first="Sadako" last="Kuno">Sadako Kuno</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinical Research Center, Utano National Hospital</s1>
<s2>Kyoto</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Mizuta, Ikuko" sort="Mizuta, Ikuko" uniqKey="Mizuta I" first="Ikuko" last="Mizuta">Ikuko Mizuta</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinical Research Center, Utano National Hospital</s1>
<s2>Kyoto</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Ohta, Mitsuhiro" sort="Ohta, Mitsuhiro" uniqKey="Ohta M" first="Mitsuhiro" last="Ohta">Mitsuhiro Ohta</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Clinical Chemistry, Kobe Pharmaceutical University</s1>
<s2>Kobe</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Maruyama, Hirofumi" sort="Maruyama, Hirofumi" uniqKey="Maruyama H" first="Hirofumi" last="Maruyama">Hirofumi Maruyama</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Third Department of Internal Medicine, Hiroshima University School of Medicine</s1>
<s2>Hiroshima</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Kaji, Ryuji" sort="Kaji, Ryuji" uniqKey="Kaji R" first="Ryuji" last="Kaji">Ryuji Kaji</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Clinical Neuroscience, Tokushima University Hospital</s1>
<s2>Tokushima</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Kawakami, Hideshi" sort="Kawakami, Hideshi" uniqKey="Kawakami H" first="Hideshi" last="Kawakami">Hideshi Kawakami</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Third Department of Internal Medicine, Hiroshima University School of Medicine</s1>
<s2>Hiroshima</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0010854</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 04-0010854 INIST</idno>
<idno type="RBID">Pascal:04-0010854</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002410</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000911</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease</title>
<author><name sortKey="Nishimura, Masataka" sort="Nishimura, Masataka" uniqKey="Nishimura M" first="Masataka" last="Nishimura">Masataka Nishimura</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Clinical Neuroscience, Tokushima University Hospital</s1>
<s2>Tokushima</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Kuno, Sadako" sort="Kuno, Sadako" uniqKey="Kuno S" first="Sadako" last="Kuno">Sadako Kuno</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinical Research Center, Utano National Hospital</s1>
<s2>Kyoto</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Mizuta, Ikuko" sort="Mizuta, Ikuko" uniqKey="Mizuta I" first="Ikuko" last="Mizuta">Ikuko Mizuta</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Clinical Research Center, Utano National Hospital</s1>
<s2>Kyoto</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Ohta, Mitsuhiro" sort="Ohta, Mitsuhiro" uniqKey="Ohta M" first="Mitsuhiro" last="Ohta">Mitsuhiro Ohta</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Clinical Chemistry, Kobe Pharmaceutical University</s1>
<s2>Kobe</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Maruyama, Hirofumi" sort="Maruyama, Hirofumi" uniqKey="Maruyama H" first="Hirofumi" last="Maruyama">Hirofumi Maruyama</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Third Department of Internal Medicine, Hiroshima University School of Medicine</s1>
<s2>Hiroshima</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Kaji, Ryuji" sort="Kaji, Ryuji" uniqKey="Kaji R" first="Ryuji" last="Kaji">Ryuji Kaji</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Clinical Neuroscience, Tokushima University Hospital</s1>
<s2>Tokushima</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Kawakami, Hideshi" sort="Kawakami, Hideshi" uniqKey="Kawakami H" first="Hideshi" last="Kawakami">Hideshi Kawakami</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Third Department of Internal Medicine, Hiroshima University School of Medicine</s1>
<s2>Hiroshima</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Allele</term>
<term>CCR2 chemokine receptor</term>
<term>Gene</term>
<term>Genetic determinism</term>
<term>Genotype</term>
<term>Human</term>
<term>Monocyte chemoattractant protein 1</term>
<term>Parkinson disease</term>
<term>Polymorphism</term>
<term>Risk factor</term>
<term>Sporadic</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Sporadique</term>
<term>Polymorphisme</term>
<term>Génotype</term>
<term>Allèle</term>
<term>Protéine MCP1</term>
<term>Récepteur chimiokine CCR2</term>
<term>Gène</term>
<term>Facteur risque</term>
<term>Déterminisme génétique</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We studied polymorphisms in the genes for monocyte chemoattractant protein 1 (MCP-1) and CC chemokine receptor (CCR)-2 in 171 Parkinson's disease (PD) patients and 340 controls. Although no associations were found in alleles or genotypes, MCP-1 -2518A/G genotype affected the age-at-onset of PD patients. This effect was also detected in a second PD group, suggesting a possible involvement of MCP-1 in PD.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>18</s2>
</fA05>
<fA06><s2>8</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>NISHIMURA (Masataka)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>KUNO (Sadako)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>MIZUTA (Ikuko)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>OHTA (Mitsuhiro)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>MARUYAMA (Hirofumi)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>KAJI (Ryuji)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>KAWAKAMI (Hideshi)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Clinical Neuroscience, Tokushima University Hospital</s1>
<s2>Tokushima</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Clinical Research Center, Utano National Hospital</s1>
<s2>Kyoto</s2>
<s3>JPN</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Clinical Chemistry, Kobe Pharmaceutical University</s1>
<s2>Kobe</s2>
<s3>JPN</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Third Department of Internal Medicine, Hiroshima University School of Medicine</s1>
<s2>Hiroshima</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>953-955</s1>
</fA20>
<fA21><s1>2003</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000112695530170</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>11 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>04-0010854</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We studied polymorphisms in the genes for monocyte chemoattractant protein 1 (MCP-1) and CC chemokine receptor (CCR)-2 in 171 Parkinson's disease (PD) patients and 340 controls. Although no associations were found in alleles or genotypes, MCP-1 -2518A/G genotype affected the age-at-onset of PD patients. This effect was also detected in a second PD group, suggesting a possible involvement of MCP-1 in PD.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Sporadique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Sporadic</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Esporádico</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Polymorphisme</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Polymorphism</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Polimorfismo</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Génotype</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Genotype</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Genotipo</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Allèle</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Allele</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Alelo</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Protéine MCP1</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Monocyte chemoattractant protein 1</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Proteina quimiocaptante monocitos 1</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Récepteur chimiokine CCR2</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>CCR2 chemokine receptor</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Receptor quimioquina CCR2</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Gène</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Gene</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Gen</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Déterminisme génétique</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Genetic determinism</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Determinismo genético</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fN21><s1>006</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000911 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000911 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:04-0010854
   |texte=   Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease

Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri